TW202021969A - 雜環衍生物及其用途 - Google Patents

雜環衍生物及其用途 Download PDF

Info

Publication number
TW202021969A
TW202021969A TW108118749A TW108118749A TW202021969A TW 202021969 A TW202021969 A TW 202021969A TW 108118749 A TW108118749 A TW 108118749A TW 108118749 A TW108118749 A TW 108118749A TW 202021969 A TW202021969 A TW 202021969A
Authority
TW
Taiwan
Prior art keywords
pyrido
pyrazine
bromo
imidazo
methylpiperazin
Prior art date
Application number
TW108118749A
Other languages
English (en)
Chinese (zh)
Inventor
高廣碩
李順玉
權永鎭
尹智勳
趙南哲
李智恩
金貞淑
Original Assignee
南韓商C&C新藥研究所
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 南韓商C&C新藥研究所 filed Critical 南韓商C&C新藥研究所
Publication of TW202021969A publication Critical patent/TW202021969A/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
    • C07D487/14—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains three hetero rings
    • C07D513/14—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
TW108118749A 2018-05-31 2019-05-30 雜環衍生物及其用途 TW202021969A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR10-2018-0062254 2018-05-31
KR20180062254 2018-05-31

Publications (1)

Publication Number Publication Date
TW202021969A true TW202021969A (zh) 2020-06-16

Family

ID=68698381

Family Applications (1)

Application Number Title Priority Date Filing Date
TW108118749A TW202021969A (zh) 2018-05-31 2019-05-30 雜環衍生物及其用途

Country Status (12)

Country Link
US (1) US20210198259A1 (cg-RX-API-DMAC7.html)
EP (1) EP3807282A4 (cg-RX-API-DMAC7.html)
JP (1) JP2021525738A (cg-RX-API-DMAC7.html)
KR (1) KR102344295B1 (cg-RX-API-DMAC7.html)
CN (1) CN112204032A (cg-RX-API-DMAC7.html)
AU (1) AU2019279421A1 (cg-RX-API-DMAC7.html)
BR (1) BR112020023946A2 (cg-RX-API-DMAC7.html)
CA (1) CA3098825A1 (cg-RX-API-DMAC7.html)
MX (1) MX2020011955A (cg-RX-API-DMAC7.html)
SG (1) SG11202010985TA (cg-RX-API-DMAC7.html)
TW (1) TW202021969A (cg-RX-API-DMAC7.html)
WO (1) WO2019231270A1 (cg-RX-API-DMAC7.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021174024A1 (en) 2020-02-28 2021-09-02 First Wave Bio, Inc. Methods of treating iatrogenic autoimmune colitis
CN116057045B (zh) 2020-06-05 2026-06-09 金耐特生物制药公司 成纤维细胞生长因子受体激酶抑制剂
EP4067357A1 (en) * 2021-03-30 2022-10-05 JW Pharmaceutical Corporation Novel crystalline form of 1-(8-bromopyrido[2,3-e][1,2,4]triazolo[4,3-a]pyrazin-4-yl)-n-methylazetidin-3-amine hydrogen sulfate monohydrate
CN113929634A (zh) * 2021-11-22 2022-01-14 山西永津集团有限公司 一种2,3-二溴喹喔啉的合成方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE358395B (cg-RX-API-DMAC7.html) * 1967-09-27 1973-07-30 Siegfried Ag
EP1613629A1 (en) * 2003-03-27 2006-01-11 Pfizer Products Inc. Substituted 4-amino 1,2,4 triazolo 4,3-a quinoxalines
JP2012502067A (ja) * 2008-09-10 2012-01-26 カリプシス・インコーポレーテッド 疾患の治療のためのヒスタミン受容体の複素環阻害剤
TW201204727A (en) * 2010-03-10 2012-02-01 Kalypsys Inc Heterocyclic inhibitors of histamine receptors for the treatment of disease
TW201206936A (en) * 2010-07-19 2012-02-16 Alcon Res Ltd Methods and compositions for the treatment of allergy
CN103889986B (zh) * 2011-09-30 2017-07-21 C&C新药研究所 新杂环衍生物及其应用
WO2014152029A2 (en) * 2013-03-15 2014-09-25 Epigenetix, Inc. Oxazolo[5,4-c]quinolin-2-one compounds as bromodomain inhibitors
US10407423B2 (en) * 2015-11-16 2019-09-10 Fundación Para La Investigación Médica Aplicada Compounds as inhibitors of DNA methyltransferases
JP7212612B2 (ja) * 2016-07-28 2023-01-25 プロメガ コーポレイション セレンテラジン類縁体

Also Published As

Publication number Publication date
EP3807282A4 (en) 2022-03-02
US20210198259A1 (en) 2021-07-01
KR102344295B1 (ko) 2021-12-29
CA3098825A1 (en) 2019-12-05
SG11202010985TA (en) 2020-12-30
EP3807282A1 (en) 2021-04-21
KR20190137013A (ko) 2019-12-10
CN112204032A (zh) 2021-01-08
JP2021525738A (ja) 2021-09-27
MX2020011955A (es) 2021-01-15
AU2019279421A1 (en) 2020-12-03
BR112020023946A2 (pt) 2021-02-23
WO2019231270A1 (en) 2019-12-05

Similar Documents

Publication Publication Date Title
TWI848954B (zh) 作為hpk1抑制劑的吡咯並[2,3-b]吡啶或吡咯並[2,3-b]吡嗪及其用途
US8772301B2 (en) Compounds for treating disorders mediated by metabotropic glutamate receptor 5, and methods of use thereof
TWI880923B (zh) 磷脂醯肌醇3-激酶抑制劑
TW202241906A (zh) 吲唑化合物
CN103476768B (zh) 6,5-杂环炔丙醇化合物及其用途
JP5654715B1 (ja) テトラヒドロイミダゾ[1,5−d][1,4]オキサゼピン誘導体(TETRAHYDROIMIDAZO[1,5−d][1,4]OXAZEPINEDERIVATIVE)
TWI431007B (zh) 作為α7菸鹼乙醯膽鹼受體配位體之啶化合物
US11427601B1 (en) Inhibitors of KEAP1-Nrf2 protein-protein interaction
JP2023538060A (ja) 二環化合物、それを含む組成物、及びそれらの使用
KR20190039591A (ko) Glp-1 수용체 아고니스트 작용을 갖는 피라졸로피리딘 유도체
US10513523B2 (en) Imidazopyrazines and pyrazolopyrimidines and their use as AMPA receptor modulators
US12492210B2 (en) Tricyclic compounds and their use
KR102838870B1 (ko) 멜라노코르틴 4 수용체 길항제로서의 스피로 화합물 및 그의 용도
TW201011026A (en) Therapeutic agents 414
WO2023006013A1 (zh) 新型parp7抑制剂及其应用
US12624034B2 (en) Non-covalent modifiers of AKT1 and uses thereof
CN115413279A (zh) P2x3调节剂
JP2025500886A (ja) 大環状btk阻害剤
CN112204032A (zh) 杂环衍生物及其用途
CN111491936A (zh) 作为pde1抑制剂的大环化合物
WO2023105387A1 (en) Melanocortin 4 receptor antagonists and uses thereof
CN102791718B (zh) 作为α-7烟碱乙酰胆碱受体配体的奎宁环化合物
HK40034987A (en) Heterocyclic derivatives and use thereof
JP7573009B2 (ja) メラノコルチン4受容体アンタゴニストとしてのスピロ化合物およびそれらの使用
TW202523331A (zh) 作為sstr4激動劑之(2s,5r)-5-(羥甲基)嗎啉-2-甲醯胺